AF
HALO icon

Amalgamated Financial’s Halozyme HALO Stock Holding History

Amalgamated Financial’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$3.8M Buy
+95,308
New +$3.39M 0.03% 619

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amalgamated Financial's HALO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Halozyme (HALO) in Q1 2022: 95,308 shares worth $3.8M. The stake represents 0.03% of the portfolio and ranks #619 among its holdings.

317 funds tracked by Wall St. Rank hold HALO as of Q1 2022.

  • Amalgamated Financial held 95,308 shares of Halozyme worth $3.8M as of Q1 2022.
  • Halozyme was a new Amalgamated Financial position in Q1 2022.
  • Halozyme made up 0.03% of Amalgamated Financial's portfolio in Q1 2022, its #619 holding.
  • 317 funds tracked by Wall St. Rank held Halozyme as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.